مقدمة فى التعرف على القوانين المنظمة لمهنة الصيدلة خاصة فيما يخص الصيدليات المجتمعية

The entire field of mathematics summarised in a single map! This shows how pure mathematics and applied mathematics relate to each other and all of the sub-topics they are made from.

Under the slogan "Health for All", the WHO office in Cairo will organize a celebration and a seminar on World Health Day next Wednesday at the headquarters of the Organization in Nasr City.

A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time - and could lead to the first new class of antibiotic drug in 30 years.

A Vancouver-based research team led by Canada's most cited neuroscientist, a daily regimen of the non-prescription NSAID (nonsteroidal anti-inflammatory drug) ibuprofen can prevent the onset of Alzheimer's disease.

A Step by Step Guide for Achieving Compliance in the Pharmaceutical, Medical Device, and Biotech Industries

Completely revised and updated to reflect the significant advances in pharmaceutical production and regulatory expectations.

This Second Edition discusses ways to improve pharmaceutical product quality while achieving compliance with global regulatory standards.

The Design Analysis Handbook: A Practical Guide to Design Validation 1st Edition - This Handbook offers design engineers and managers immediately useful, meat-and-potatoes techniques for achieving design validation by analysis in an easy-to-read style

Principles and Practices of Method Validation is an overview of the most recent approaches used for method validation in cases when a large number of analytes are determined from a single aliquot and where a large number of samples are to be analysed.

Author and business adviser Josh Kaufman reveals a new approach for acquiring new skills quickly with just a small amount of practice each day.

Many countries around the globe have pushed local pharmaceutical production to the top of their agenda in recent years.

GlaxoSmithKline plc (LSE/NYSE: GSK) today announces that it has reached an agreement with Novartis for the buyout of Novartis' 36.5% stake in their Consumer Healthcare Joint Venture for $13 billion (£9.2 billion).